|

Pedmark® STS Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • University of Arizona1

Indications

  • Thoracic Cancer1
  • Solid Tumor Malignancies1
  • Testicular Cancer1
  • Head and Neck Cancer1
  • Cancer1

Tucson, Arizona1 trial

Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)

University of Arizona Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.